Clinical trial
Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy (SCS-IMRT)
To test the hypothesis that parotid gland stem cell sparing intensity modulated radiotherapy in HNC patients reduces the risk of parotid gland dysfunction and xerostomia as compared to conventional parotid gland sparing intensity modulated radiotherapy.
Category | Value |
---|---|
Study start date | 2013-09-27 |